ProKidney Corp PROK:NASDAQ

RT Quote | Last NYSE, VOL From CTA | USD
Last | 12:51 PM EDT
3.79quote price arrow down-0.13 (-3.32%)
Volume
227,531
52 week range
1.12 - 13.51
Loading...
  • Open3.94
  • Day High3.94
  • Day Low3.73
  • Prev Close3.92
  • 52 Week High13.51
  • 52 Week High Date08/11/23
  • 52 Week Low1.12
  • 52 Week Low Date11/17/23

Key Stats

  • Market Cap878.135M
  • Shares Out231.70M
  • 10 Day Average Volume0.75M
  • Dividend-
  • Dividend Yield-
  • Beta1.11
  • YTD % Change112.92

KEY STATS

  • Open3.94
  • Day High3.94
  • Day Low3.73
  • Prev Close3.92
  • 52 Week High13.51
  • 52 Week High Date08/11/23
  • 52 Week Low1.12
  • 52 Week Low Date11/17/23
  • Market Cap878.135M
  • Shares Out231.70M
  • 10 Day Average Volume0.75M
  • Dividend-
  • Dividend Yield-
  • Beta1.11
  • YTD % Change112.92

RATIOS/PROFITABILITY

  • EPS (TTM)-0.57
  • P/E (TTM)-6.63
  • Fwd P/E (NTM)-4.99
  • EBITDA (TTM)-146.599M
  • ROE (TTM)-7.28%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-0.01%

EVENTS

  • Earnings Date08/08/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On ProKidney Corp

 

Profile

MORE
ProKidney Corp. is a clinical-stage biotechnology company. The Company is focused on cell therapy platforms capable of treating multiple chronic kidney diseases (CKD) using a patient’s own cells isolated from the patient intended for treatment. The Company’s lead product candidate, Renal Autologous Cell Therapy (REACT), is designed to preserve kidney function in a CKD patient’s diseased kidneys. REACT is a product that includes autologous Selected Renal Cells (SRCs) prepared...
Pablo Legorreta
Chairman of the Board
Bruce Culleton M.D.
Chief Executive Officer, Director
James Coulston CPA
Chief Financial Officer
Ulrich Ernst Ph.D.
Executive Vice President - Technical Operations
Address
2000 Frontis Plaza Blvd., Suite 250
Winston-salem, NC
27103
United States

Top Peers

SYMBOLLASTCHG%CHG
XFOR
X4 Pharmaceuticals Inc
0.9988+0.0226+2.3151%
GLSI
Greenwich Lifesciences Inc
14.73-0.02-0.11%
GOSS
Gossamer Bio Inc
0.7323-0.0099-1.3339%
ELEV
Elevation Oncology Inc
3.60-0.13-3.49%
DRTS
Alpha Tau Medical Ltd
2.69+0.04+1.51%